Shareholders Back Pharma Firm’s N50bn Rights Issue

Shareholders of MeCure Industries Plc have approved a proposed fifty billion Naira rights issue to boost working capital and fund regional expansion. The decision follows a sixty-nine percent growth in the company's 2025 revenue to seventy-seven point six nine billion Naira.